Intuitive SurgicalMIL:1ISRG +0.15%74 EBITDA Margin % is 38.09% as of Mar. 2026, which is 8% above its 10-year median of 35.36. GuruFocus rates MIL:1ISRG with a GF Score™ of 74/100 and a GF Value™ of €537.04 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 816 Medical Devices & Instruments companies, Intuitive Surgical ranks better than 94.61% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Intuitive Surgical's EBITDA for the
three
months ended in Mar. 2026 was €913 Mil. Intuitive Surgical's Revenue for the
three
months ended in Mar. 2026 was €2,397 Mil. Therefore, Intuitive Surgical's EBITDA margin for the quarter that ended in Mar. 2026 was 38.09%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Intuitive Surgical EBITDA Margin % Related Terms
Intuitive Surgical EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Intuitive Surgical's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1ISRG vs BDX, MDLN, RMD: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Intuitive Surgical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intuitive Surgical EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intuitive Surgical's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Intuitive Surgical's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intuitive Surgical (MIL:1ISRG) has a EBITDA Margin % of 38.09% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Intuitive Surgical and its competitors. This is near median its historical median of 35.36. Over the past decade, Intuitive Surgical's EBITDA Margin % has ranged from 30.42 to 38.49. According to the industry distribution chart, Intuitive Surgical ranks #44 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 5.4%.
Is Intuitive Surgical's EBITDA Margin % too high?
Intuitive Surgical's current EBITDA Margin % of 38.09% is near median its 10-year median of 35.36. Over the past 10 years, this metric has ranged from a low of 30.42 to a high of 38.49. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Intuitive Surgical's value of 38.09% is 409.6% above this industry median. Based on the distribution chart, Intuitive Surgical ranks #44 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Intuitive Surgical has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intuitive Surgical's EBITDA Margin % compare to BDX and MDLN?
According to the Medical Devices & Instruments industry distribution chart, Intuitive Surgical ranks #44 out of 816 companies for EBITDA Margin %. This places Intuitive Surgical in the top 5% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. Intuitive Surgical's value of 38.09% is 409.6% above this benchmark. Historically, Intuitive Surgical's own EBITDA Margin % has ranged from 30.42 to 38.49 over the past decade. While the company's 10-year median is 35.36 vs. the industry median of 7.48, Intuitive Surgical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Intuitive Surgical's current EBITDA Margin % of 38.09% is 409.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Intuitive Surgical and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intuitive Surgical's current EBITDA Margin % is 38.09%, which is near median its own 10-year median of 35.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intuitive Surgical stock overvalued right now?
Based on GuruFocus' analysis, Intuitive Surgical (MIL:1ISRG) is currently considered Significantly Undervalued. The stock's GF Value™ is €537.04, compared to a current price of €357.15 — trading 33.5% below its estimated fair value. The current EBITDA Margin % is 38.09%, which is near median its 10-year median of 35.36 and 409.6% above the Medical Devices & Instruments industry median of 7.48. Intuitive Surgical's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Intuitive Surgical (MIL:1ISRG), the current EBITDA Margin % is 38.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intuitive Surgical (MIL:1ISRG) Overvalued in 2026?
Based on GuruFocus' analysis, Intuitive Surgical stock appears to be undervalued.
The current stock price of €357.15 is trading 33.5% below its estimated GF Value™ of €537.04.
GuruFocus considers Intuitive Surgical to be Significantly Undervalued.
Key valuation signals for MIL:1ISRG:
EBITDA Margin %: 38.09% (near median its 10-year median of 35.36)
GF Value™: €537.04 vs. price of €357.15 (33.5% below fair value)
Industry Position: 409.6% above the Medical Devices & Instruments median (#44 of 816)
No single metric tells the full story. See the MIL:1ISRG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
74GF Score
Get the complete analysis for MIL:1ISRG
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1ISRG has been successfully added to your 
